See more : AbbVie Inc. (0QCV.L) Income Statement Analysis – Financial Results
Complete financial analysis of Go Life International Limited (GLI.JO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Go Life International Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- SIM Technology Group Limited (SIMTF) Income Statement Analysis – Financial Results
- Somerley Capital Holdings Limited (8439.HK) Income Statement Analysis – Financial Results
- Beijing Jingxi Culture & Tourism Co.,Ltd (000802.SZ) Income Statement Analysis – Financial Results
- LET Group Holdings Limited (1383.HK) Income Statement Analysis – Financial Results
- Paradigm Oil and Gas, Inc. (PDGO) Income Statement Analysis – Financial Results
Go Life International Limited (GLI.JO)
About Go Life International Limited
Go Life International Limited engages in the investment holding activities. It primarily focuses on medical sector. The company was formerly known as Go Life International PCC and changed its name to Go Life International Limited in March 2015. Go Life International Limited was incorporated in 2010 and is based in Midlands, Mauritius.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 4.14K | 1.82M | 1.20K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 8.78 | 22.47 | 17.91 | 1.40 | 0.00 | 32.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | -8.78 | -22.47 | -17.91 | 4.13K | 1.82M | 1.17K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 99.97% | 100.00% | 97.29% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | -7.95K | 101.57K | 13.93K | 23.00K | 31.93K | 16.69 | 9.13K | 36.90K | 20.33K | 23.52K | 13.90K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 105.58 | -7.95K | 101.57K | 13.93K | 23.00K | 31.93K | 17.01 | 9.13K | 36.90K | 20.33K | 23.52K | 13.90K |
| Other Expenses | 0.00 | 70.79K | 159.26K | 392.71K | 48.19K | 792.77K | 0.00 | 40.25K | 17.56K | 16.40K | 29.76K | 81.46K |
| Operating Expenses | 105.58 | 62.84K | 260.82K | 406.64K | 71.19K | 824.69K | 902.10 | 49.38K | 54.45K | 36.73K | 53.28K | 95.36K |
| Cost & Expenses | -105.58 | 62.84K | 260.82K | 406.64K | 71.19K | 824.69K | -869.43 | 49.38K | 54.45K | 36.73K | 53.28K | 95.36K |
| Interest Income | 14.36 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 548.39 | 313.10K | 243.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 105.58 | 1.00 | 206.30K | 171.86K | 27.50 | 3.41K | 6.95 | -143.26K | 6.32M | 8.59M | 330.45K | -431.28K |
| EBITDA | 14.36 | -62.84K | -260.82K | -406.64K | -71.19K | 997.93K | 252.49 | -192.64K | 2.75M | 4.33M | -53.28K | -95.36K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,721.23% | 54.86% | 20.97% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -105.58 | -62.84K | -260.82K | -406.64K | -71.19K | 507.43K | 245.55 | -49.38K | -3.57M | -4.26M | -383.72K | 335.92K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,721.23% | 27.89% | 20.39% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 14.36 | 2.00 | 0.00 | -35.26M | 476.00 | 173.98K | -219.55 | 171.67K | -3.57M | -4.26M | 0.00 | 0.00 |
| Income Before Tax | -91.22 | -62.84K | -260.82K | -35.26M | -70.72K | 681.41K | 25.99 | 122.29K | -3.57M | -4.26M | -383.72K | 335.92K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,709.72% | 37.46% | 2.16% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -1.00 | -260.82 | 34.85M | -476.00 | 105.97K | 7.10 | -171.67K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -91.22 | -62.84K | -260.82K | -70.11M | -70.72K | 575.45K | 18.90 | 122.29K | -3.57M | -4.26M | -383.72K | 335.92K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -1,709.72% | 31.63% | 1.57% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 | -0.04 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.08 | 0.00 | 0.00 | 0.00 | 0.00 | -0.04 | -0.04 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 773.07K | 900.00M | 900.00M | 900.00M | 900.00M | 900.00M | 715.27K | 96.65M | 96.65M | 96.65M | 96.65M | 96.65M |
| Weighted Avg Shares Out (Dil) | 767.50K | 900.00M | 900.00M | 900.00M | 900.00M | 900.00M | 726.85K | 96.65M | 96.65M | 96.65M | 96.65M | 96.65M |
Source: https://incomestatements.info
Category: Stock Reports